Neuberger Berman Group LLC Nevro Corp Transaction History

Neuberger Berman Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$44.22 - $75.47 $8.53 Million - $14.6 Million	-192,800 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$72.38 - $92.5 $695,571 - $888,925	-9,610 Reduced 4.75%	192,800 $15.4 Million
Q1 2018 May 08, 2018	BUY	$69.46 - $88.57 $2.43 Million - $3.1 Million	35,000 Added 20.91%	202,410 $17.5 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $4.06 Million - $5.75 Million	-61,580 Reduced 26.89%	167,410 $11.6 Million
Q3 2017 Nov 15, 2017	BUY	$80.87 - $91.08 $18.5 Million - $20.9 Million	228,990	228,990 $20.8 Million

173

37.4M

80.4K

898K

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $295M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.